Fast track designation granted for alemtuzumab for multiple sclerosis (MS) - ONA
Links shared publicly online about this topic.
- 1,092total visits
Fast track designation granted for alemtuzumab for multiple sclerosis (MS) - ONA
View full resource at oncologynurseadvisor.com
Tags: Multiple Sclerosis, FDA, Genzyme
Most Recently Shared on June 15, 2010 at 4:08 pm By:
Fast track designation granted for alemtuzumab for multiple sclerosis (MS) http://goo.gl/fb/zMrWT
Fast track designation granted for alemtuzumab for multiple sclerosis (MS) - MPR
empr.com — “Genzyme announced that the FDA has granted fast track designation to alemtuzumab for the treatment of multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on June 15, 2010 at 4:45 pm By:
MPR News: Fast track designation granted for alemtuzumab for multiple sclerosis (MS): Genzyme announced that the F... http://bit.ly/dd4yxx
FDA grants Fast Track status for Genzyme's alemtuzumab development program for MS
news-medical.net — “Genzyme Corporation announced today that its alemtuzumab for multiple sclerosis development program has been granted Fast Track status by the U.S. Food and Drug Administration (FDA). This designation covers patients with relapsing-remitting forms of the disease.” View full resource at news-medical.net
Most Recently Shared on June 15, 2010 at 6:12 am By:
FDA grants Fast Track status for Genzyme's alemtuzumab development program for MS: Genzyme Corporation announced t... http://bit.ly/a2yIsx
Advertisement
